Skip to main content

Habib J. Dable

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Habib J. Dable

Habib J. Dable is recorded as Board Member at Jade Biosciences, Inc. (JBIO). Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Habib J. Dable resigned as Aerovate's board of directors, effective April 28, 2025. Jade Biosciences, Inc. reported in an 8-K filed July 11, 2023 that Habib J. Dable was appointed member of the Board, effective July 10, 2023.

“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Jade Biosciences, Inc. Form 8-K, filed May 1, 2025 · Read the filing
“Effective as of July 10, 2023 (the "Effective Date"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Aerovate Therapeutics, Inc. (the "Company"), the Board appointed Habib J. Dable as a member of the Board.”
Jade Biosciences, Inc. Form 8-K, filed July 11, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Jade Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.